SPARTHA Medical develops personalised multifunctional coatings with antimicrobial and anti-inflammatory properties.
SPARTHA Medical has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in January 2022.
SPARTHA Medical's investors include Bpifrance, European Innovation Council, Alsace Business Angels, WiSEED, YEAST.
SPARTHA Medical is headquartered in Strasbourg, France.
SPARTHA Medical develops personalised multifunctional coatings with antimicrobial and anti-inflammatory properties.
SPARTHA Medical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SPARTHA Medical — Funding & Investors." VCBacked, January 25, 2022, https://www.vcbacked.co/company/spartha-medical. Accessed September 30, 2026.
VCBacked. (2022). SPARTHA Medical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/spartha-medical
{{cite web |title=SPARTHA Medical — Funding & Investors |url=https://www.vcbacked.co/company/spartha-medical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated